Skip to content

The analysis of intestinal mucosal barrier of the inflammatory bowel disease.

The analysis of intestinal mucosal barrier of the inflammatory bowel disease. - The analysis of intestinal mucosal barrier of the inflammatory bowel disease.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000042399
Enrollment
100
Registered
2020-11-09
Start date
2020-11-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory bowel disease

Interventions

None listed

Sponsors

kyushu university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with IBD and undergoing total colonoscopy. (2) Patients who fully understand the study plan and are able to give their consent. (3) Patient who are older than 20 years old at the time of obtaining consent or Patients who are older than 16 years old of age at the time of obtaining the consent of their parents or guardians.

Exclusion criteria

Exclusion criteria: (1) Patients for whom total colonoscopy is usually contraindicated (e.g., patients with ileus, gastrointestinal perforation, severe respiratory and cardiovascular diseases). (2) Patients with poor general condition (e.g., PS level 3 or higher). (3) Patients for whom informed consent cannot be obtained. (4) Patients who are deemed by the researcher to be unsuitable as research subjects.

Design outcomes

Primary

MeasureTime frame
To determine if there is any change in mucosal impedance values during IBD remission compared to control patients.

Countries

Japan

Contacts

Public ContactKei Nishioka

Kyushu university Department of Medicine and Bioregulatory Science

n-kei@med.kyushu-u.ac.jp0926425082

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026